Treatment of palatal myoclonus with sumatriptan

Movement Disorders

Volumn 11, Issue 6, 1996, Pages 748-751

  Scott, Burton L ^a   Evans, Randolph W ^b   Jankovic, Joseph ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SUMATRIPTAN; SUMATRIPTAN SUCCINATE;

ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; INVOLUNTARY MOVEMENT; MOTOR DYSFUNCTION; MYOCLONUS; ORAL DRUG ADMINISTRATION; PALATE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ADULT; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; MYOCLONUS; PALATE, SOFT; SEROTONIN AGONISTS; SUMATRIPTAN;

EID: 0029823676     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.870110628     Document Type: Article

References (45)

1. Lapresle J. Palatal myoclonus. Adv Neurol 1986;43:265-73.
2. Deuschl G, Toro C, Valls-Sole J, Zeffiro T, Zee DS, Hallett M. Symptomatic and essential palatal tremor. 1. Clinical, physiological and MRI analysis. Brain 1994;117:775-88.
3. Deuschl G, Toro C, Hallett M. Symptomatic and essential palatal tremor. 2. Differences of palatal movements. Mov Disord 1994;9:676-8.
4. Deuschl G, Lohle E, Heinen F, Lucking CH. Earclick in palatal tremor: its origin and treatment with botulinum toxin. Neurology 1991;41:1677-9.
5. Marsden CD, Hallett M, Fahn S. The nosology and pathophysiology of myoclonus. In: Marsden CD, Fahn S, eds. Neurology 2. Movement disorders. London: Butterworth Scientific, 1981:196-248.
6. Deuschl G, Mischke G, Schenck E, Schulte-Monting J, Lucking CH. Symptomatic and essential rhythmic palatal myoclonus. Brain 1990;113:1645-72.
7. Jankovic J, Pardo R. Segmental myoclonus. Clinical and pharmacologic study. Arch Neurol 1986;43:1025-31.
8. Emre M. Palatal myoclonus occurring during complex partial status epilepticus. J Neurol 1992;239:228-30.
9. Tatum WO, Sperling MR, Jacobstein JG. Epileptic palatal myoclonus. Neurology 1991;41:1305-6.
10. Yamanouchi H, Kasai H, Sakuragawa N, Kurokawa T. Palatal myoclonus in Krabbe disease. Brain Dev 1991;13:355-8.
11. Sakai T, Shiraishi S, Murakami S. Palatal myoclonus responding to carbamazepine. Ann Neurol 1981;9:199-200.
12. Magnussen I, Dupont E, Prange-Hansen A, de Fine Olivarius B. Palatal myoclonus treated with 5-hydroxytryptophan and a decarboxylase-inhibitor. Acta Neurol Scand 1977;55: 251-3.
13. Williams A, Goodenberger D, Calne DB. Palatal myoclonus following herpes zoster ameliorated by 5-hydroxytryptophan and carbidopa [Abstract]. Neurology 1978;28:358-9.
14. Hanson B, Ficara A, McQuade M. Bilateral palatal myoclonus. Pathophysiology and report of a case. Oral Surg 1985; 59:479-81.
15. Hazell JWP. Tinnitus II: surgical management of conditions associated with tinnitus and somatosounds. J Otolaryngol 1990;19:6-10.
16. De Bleecker J, Van Landegem W, Crevits L, De Reuck J. Unusual CT and MRI findings in palatal myoclonus. Acta Neurol Scand 1992;85:150-3.
17. Bakheit A, Behan PO. Palatal myoclonus successfully treated with clonazepam. J Neurol Neurosurg Psychiatry 1990;53:806.
18. Jabbari B, Rosenberg M, Scherokman B, Gunderson CH, McBurney JW, McClintock W. Effectiveness of trihexyphenidyl against pendular nystagmus and palatal myoclonus: evidence of cholinergic dysfunction. Mov Disord 1987; 2:93-8.
19. Iwasaki Y, Kinoshita M, Ikeda K, Shiojima T. Palatal myoclonus following Behcet's disease ameliorated by ceruletide, a potent analogue of CCK octapeptide. J Neurol Sci 1991;105:12-3.
20. Le Pajolec C, Marion MH, Bobin S. Acouphene objectif et myoclonies velaires. Nouvelle approche therapeutique. Ann Otolaryngol (Paris) 1990;107:363-5.
21. Greenberg E, Giladi N, Meer J, Uri N, Honigman S. Botulinum toxin for palatal myoclonus and spastic dysphonia. Harefuah 1993;125:402-4.
22. Saeed SR, Brookes GB. The use of Clostridium botulinum toxin in palatal myoclonus. A preliminary report. J Laryngol Otol 1993;107:208-10.
23. Deuschl G, Lohle E, Toro C, Hallett M, Lebovics RS. Botulinum toxin treatment of palatal tremor (myoclonus). In: Jankovic J, Hallett M, eds. Therapy with botulinum toxin. New York: Marcel Dekker, 1994:567-76.
24. Scott AK. Sumatriptan clinical pharmacokinetics. Clin Pharmacokinet 1994;27:337-44.
25. Subcutaneous Sumatriptan International Study Group. Treatment of migraine attacks with sumatriptan. N Engl J Med 1991;325:316-21.
26. Lapresle J, Ben Hamida M. The dentato-olivary pathway. Somatotopic relationship between the dentate nucleus and the contralateral inferior olive. Arch Neurol 1970;22:135-43.
27. Matsuo F, Ajax ET. Palatal myoclonus and denervation supersensitivity in the central nervous system. Ann Neurol 1979;5:72-8.
28. Scott BL, Jankovic J. Delayed-onset progressive movement disorders after static brain lesions. Neurology 1996;46:68-74.
29. Dubinsky RM, Hallett M, Di Chiro G, Fulham MD, Schwankhaus J. Increased glucose metabolism in the medulla of patients with palatal myoclonus. Neurology 1991; 41:557-62.
30. Pierot L, Cervera-Pierot P, Delattre J-Y, Duyckaerts C, Chiras J, Brunet P. Palatal myoclonus and inferior olivary lesions: MRI-pathologic correlation. J Comput Assist Tomogr 1992;16:160-3.
31. Barron KD, Dentinger MP, Koeppen AH. Fine structure of neurons of the hypertrophied human inferior olive. J Neuropathol Exp Neurol 1982;41:186-203.
32. Hefter H, Logigian E, Witte OW, Reiners K, Freund H-J. Oscillatory activity in different motor subsystems in palatal myoclonus. A case report. Acta Neurol Scand 1992;86:176-83.
33. Tomkinson A, Craven C, Brown MJKM. Palatal myoclonus affected by neck position. J Laryngol Otol 1995;109:61-2.
34. Hoyer D. The 5-HT receptor family: ligands, distribution and receptor-effector coupling. In: Rodgers RJ, Cooper SJ, eds. 5-HTIA agonists, 5-HT3 antagonists and benzodiazepines: their comparative behavioral pharmacology. New York: Wiley, 1991:31-57.
35. 1D receptors. Naunyn Schmiedebergs Arch Pharmacol 1989; 340:135-8.
36. 1D binding sites. Eur J Pharmacol 1989;163:133-6.
37. 1D receptor: a progress review. Neurochem Res 1990;15:567-82.
38. 1B recognition sites. Brain Res 1986;376:85-96.
39. 1D) in the human brain by autoradiography. Neurosci Lett 1988; 88:11-6.
40. Pazos A, Palacios JM. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res 1985;346:205-30.
41. Plosker GL, McTavish D. Sumatriptan. A reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache. Drugs 1994;47:622-51.
42. Humphrey PPA, Goadsby PJ. The mode of action of sumatriptan is vascular? A debate. Cephalalgia 1994;14:401-10.
43. 2 recognition sites. Brain Res 1986;376:97-107.
44. Tuor UI, Simone C, Bascaramurty S. Local blood-brain barrier in the newborn rabbit: postnatal changes in α-aminoisobutyric acid transfer within medulla, cortex, and selected brain areas. J Neurochem 1992;59:999-1007.
45. Borison HL, Borison R, McCarthy LE. Brain stem penetration by horseradish peroxidase from the cerebrospinal fluid spaces in the cat. Exp Neurol 1980;69:271-89.